{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T23:50:22Z","timestamp":1788825022895,"version":"build-2803163510"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,7,13]],"date-time":"2022-07-13T00:00:00Z","timestamp":1657670400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,7,13]],"date-time":"2022-07-13T00:00:00Z","timestamp":1657670400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"National Research Foundation of Korea grant funded by the Korean Government","award":["NRF-2018R1A5A2025079"],"award-info":[{"award-number":["NRF-2018R1A5A2025079"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Respir Res"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Sarcopenia is a well-established risk factor for atherosclerotic cardiovascular disease (ASCVD), but its relationship with chronic obstructive pulmonary disease (COPD) has not been fully determined. This study is aimed to investigate the association between sarcopenia and risk for ASCVD in patients with COPD, independent of central obesity and fat mass.\n<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Data regarding 704 men with COPD (mean age: 63.4\u00a0years) were extracted from the 2008 to 2011 Korean National Health and Nutrition Examination Surveys. Sarcopenia index and fat mass were assessed using dual-energy X-ray absorptiometry. Sarcopenia was defined according to the presence of sarcopenia index values\u2009&lt;\u20091 standard deviation from the cutoff (0.774) among the study participants. ASCVD risk was evaluated using American College of Cardiology\/American Heart Association guidelines. High probability of ASCVD was defined as ASCVD risk\u2009&gt;\u200920%.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The quartile-stratified sarcopenia index was negatively associated with ASCVD risk (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001). ASCVD risk and prevalence of high ASCVD risk were significantly greater in sarcopenic participants than in non-sarcopenic participants, regardless of central obesity and fat mass (all <jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001). Multivariate regression analyses demonstrated an independent association between sarcopenia and ASCVD risk (estimated\u2009\u00b1\u2009standard error\u2009=\u20093.63\u2009\u00b1\u20090.77%, <jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001) and high ASCVD risk (odds ratio [OR]\u2009=\u20092.32, 95% confidence interval [CI] 1.05\u20135.15, <jats:italic>P<\/jats:italic>\u2009=\u20090.039). Furthermore, sarcopenia was an independent factor for high ASCVD risk in participants with moderate to very severe airflow limitation (OR\u2009=\u20092.97, 95% CI 1.06\u20138.36, <jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Sarcopenia was significantly associated with an increased risk for ASCVD in men with COPD, independent of central obesity and fat mass. High ASCVD risk was significantly associated with sarcopenia, particularly in participants with moderate to very severe airflow limitation.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12931-022-02109-3","type":"journal-article","created":{"date-parts":[[2022,7,13]],"date-time":"2022-07-13T22:04:58Z","timestamp":1657749898000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Sarcopenia is associated with cardiovascular risk in men with COPD, independent of adiposity"],"prefix":"10.1186","volume":"23","author":[{"given":"Ah Young","family":"Leem","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young Sam","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kung Soo","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moo Suk","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young Ae","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young-Mok","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1589-4142","authenticated-orcid":false,"given":"Ji Ye","family":"Jung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,7,13]]},"reference":[{"key":"2109_CR1","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1586\/ers.11.62","volume":"5","author":"AR Patel","year":"2011","unstructured":"Patel AR, Hurst JR. Extrapulmonary comorbidities in chronic obstructive pulmonary disease: state of the art. Expert Rev Respir Med. 2011;5:647\u201362.","journal-title":"Expert Rev Respir Med"},{"key":"2109_CR2","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1016\/j.jamda.2016.05.002","volume":"17","author":"N Cebron Lipovec","year":"2016","unstructured":"Cebron Lipovec N, Schols AMWJ, van den Borst B, Beijers RJHCG, Kosten T, Omersa D, Lainscak M. Sarcopenia in advanced COPD affects cardiometabolic risk reduction by short-term high-intensity pulmonary rehabilitation. J Am Med Directors Assoc. 2016;17:814\u201320.","journal-title":"J Am Med Directors Assoc"},{"key":"2109_CR3","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1016\/j.chest.2016.12.006","volume":"151","author":"JA Hwang","year":"2017","unstructured":"Hwang JA, Kim YS, Leem AY, Park MS, Kim SK, Chang J, Jung JY. Clinical implications of sarcopenia on decreased bone density in men with COPD. Chest. 2017;151:1018\u201327.","journal-title":"Chest"},{"key":"2109_CR4","doi-asserted-by":"publisher","first-page":"82","DOI":"10.3109\/15412555.2014.908835","volume":"12","author":"JH Chung","year":"2015","unstructured":"Chung JH, Hwang H-J, Han CH, Son BS, Kim DH, Park MS. Association between sarcopenia and metabolic syndrome in chronic obstructive pulmonary disease: the Korea National Health and Nutrition Examination Survey (KNHANES) from 2008 to 2011. COPD J Chronic Obstr Pulm Dis. 2015;12:82\u20139.","journal-title":"COPD J Chronic Obstr Pulm Dis"},{"key":"2109_CR5","doi-asserted-by":"publisher","first-page":"1772","DOI":"10.1002\/hep.26716","volume":"59","author":"HC Hong","year":"2014","unstructured":"Hong HC, Hwang SY, Choi HY, Yoo HJ, Seo JA, Kim SG, Kim NH, Baik SH, Choi DS, Choi KM. Relationship between sarcopenia and nonalcoholic fatty liver disease: the Korean Sarcopenic Obesity Study. Hepatology. 2014;59:1772\u20138.","journal-title":"Hepatology"},{"key":"2109_CR6","doi-asserted-by":"publisher","first-page":"264","DOI":"10.3346\/jkms.2015.30.3.264","volume":"30","author":"J-H Kim","year":"2015","unstructured":"Kim J-H, Cho JJ, Park YS. Relationship between sarcopenic obesity and cardiovascular disease risk as estimated by the Framingham risk score. J Korean Med Sci. 2015;30:264\u201371.","journal-title":"J Korean Med Sci"},{"key":"2109_CR7","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1111\/jgs.12652","volume":"62","author":"JL Atkins","year":"2014","unstructured":"Atkins JL, Whincup PH, Morris RW, Lennon LT, Papacosta O, Wannamethee SG. Sarcopenic obesity and risk of cardiovascular disease and mortality: a population-based cohort study of older men. J Am Geriatr Soc. 2014;62:253\u201360.","journal-title":"J Am Geriatr Soc"},{"key":"2109_CR8","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1093\/ije\/dyt228","volume":"43","author":"S Kweon","year":"2014","unstructured":"Kweon S, Kim Y, Jang MJ, Kim Y, Kim K, Choi S, Chun C, Khang YH, Oh K. Data resource profile: the Korea National Health and Nutrition Examination Survey (KNHANES). Int J Epidemiol. 2014;43:69\u201377.","journal-title":"Int J Epidemiol"},{"key":"2109_CR9","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1183\/09031936.05.00034805","volume":"26","author":"MR Miller","year":"2005","unstructured":"Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, Crapo R, Enright P, van der Grinten CPM, Gustafsson P, et al. Standardisation of spirometry. Eur Respir J. 2005;26:319\u201338.","journal-title":"Eur Respir J"},{"key":"2109_CR10","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1046\/j.1532-5415.2002.50216.x","volume":"50","author":"I Janssen","year":"2002","unstructured":"Janssen I, Heymsfield SB, Ross R. Low relative skeletal muscle mass (sarcopenia) in older persons is associated with functional impairment and physical disability. J Am Geriatr Soc. 2002;50:889\u201396.","journal-title":"J Am Geriatr Soc"},{"key":"2109_CR11","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1186\/1471-2458-13-629","volume":"13","author":"P Liu","year":"2013","unstructured":"Liu P, Ma F, Lou H, Liu Y. The utility of fat mass index vs. body mass index and percentage of body fat in the screening of metabolic syndrome. BMC Public Health. 2013;13:629.","journal-title":"BMC Public Health"},{"key":"2109_CR12","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1038\/sj.ijo.0802037","volume":"26","author":"Y Schutz","year":"2002","unstructured":"Schutz Y, Kyle UU, Pichard C. Fat-free mass index and fat mass index percentiles in Caucasians aged 18\u201398 y. Int J Obes Relat Metab Disord. 2002;26:953\u201360.","journal-title":"Int J Obes Relat Metab Disord"},{"key":"2109_CR13","doi-asserted-by":"publisher","first-page":"561","DOI":"10.4093\/dmj.2011.35.6.561","volume":"35","author":"SW Oh","year":"2011","unstructured":"Oh SW. Obesity and metabolic syndrome in Korea. Diabetes Metab J. 2011;35:561\u20136.","journal-title":"Diabetes Metab J"},{"key":"2109_CR14","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1002\/hep.28376","volume":"63","author":"Y-H Lee","year":"2016","unstructured":"Lee Y-H, Kim SU, Song K, Park JY, Kim DY, Ahn SH, Lee B-W, Kang ES, Cha B-S, Han K-H. Sarcopenia is associated with significant liver fibrosis independently of obesity and insulin resistance in nonalcoholic fatty liver disease: Nationwide surveys (KNHANES 2008\u20132011). Hepatology. 2016;63:776\u201386.","journal-title":"Hepatology"},{"key":"2109_CR15","doi-asserted-by":"publisher","first-page":"S49","DOI":"10.1161\/01.cir.0000437741.48606.98","volume":"129","author":"DC Goff Jr","year":"2014","unstructured":"Goff DC Jr, Lloyd-Jones DM, Bennett G, Coady S, D\u2019Agostino RB, Gibbons R, Greenland P, Lackland DT, Levy D, O\u2019Donnell CJ, et al. 2013 ACC\/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines. Circulation. 2014;129:S49-73.","journal-title":"Circulation"},{"key":"2109_CR16","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1161\/01.CIR.0000133317.49796.0E","volume":"110","author":"SM Grundy","year":"2004","unstructured":"Grundy SM, Cleeman JI, Merz CN, Brewer HB Jr, Clark LT, Hunninghake DB, Pasternak RC, Smith SC Jr, Stone NJ. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Circulation. 2004;110:227\u201339.","journal-title":"Circulation"},{"key":"2109_CR17","doi-asserted-by":"publisher","first-page":"190049","DOI":"10.1183\/16000617.0049-2019","volume":"28","author":"E Benz","year":"2019","unstructured":"Benz E, Trajanoska K, Lahousse L, Schoufour JD, Terzikhan N, De Roos E, de Jonge GB, Williams R, Franco OH, Brusselle G, Rivadeneira F. Sarcopenia in COPD: a systematic review and meta-analysis. Eur Respir Rev. 2019;28:190049.","journal-title":"Eur Respir Rev"},{"key":"2109_CR18","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1002\/jcsm.12600","volume":"11","author":"W Sep\u00falveda-Loyola","year":"2020","unstructured":"Sep\u00falveda-Loyola W, Osadnik C, Phu S, Morita AA, Duque G, Probst VS. Diagnosis, prevalence, and clinical impact of sarcopenia in COPD: a systematic review and meta-analysis. J Cachexia Sarcopenia Muscle. 2020;11:1164\u201376.","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"2109_CR19","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0060119","volume":"8","author":"SO Chin","year":"2013","unstructured":"Chin SO, Rhee SY, Chon S, Hwang YC, Jeong IK, Oh S, Ahn KJ, Chung HY, Woo JT, Kim SW, et al. Sarcopenia is independently associated with cardiovascular disease in older Korean adults: the Korea National Health and Nutrition Examination Survey (KNHANES) from 2009. PLoS ONE. 2013;8: e60119.","journal-title":"PLoS ONE"},{"key":"2109_CR20","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0010805","volume":"5","author":"P Srikanthan","year":"2010","unstructured":"Srikanthan P, Hevener AL, Karlamangla AS. Sarcopenia exacerbates obesity-associated insulin resistance and dysglycemia: findings from the National Health and Nutrition Examination Survey III. PLoS ONE. 2010;5: e10805.","journal-title":"PLoS ONE"},{"key":"2109_CR21","doi-asserted-by":"publisher","first-page":"182","DOI":"10.4093\/dmj.2016.40.3.182","volume":"40","author":"HC Jang","year":"2016","unstructured":"Jang HC. Sarcopenia, frailty, and diabetes in older adults. Diabetes Metab J. 2016;40:182\u20139.","journal-title":"Diabetes Metab J"},{"key":"2109_CR22","doi-asserted-by":"crossref","unstructured":"Snijder MB, Henry RMA, Visser M, Dekker JM, Seidell JC, Ferreira I, Bouter LM, Yudkin JS, Westerhof N, Stehouwer CDA. Regional body composition as a determinant of arterial stiffness in the elderly: the Hoorn Study. J Hypertension. 2004; 22.","DOI":"10.1097\/00004872-200412000-00016"},{"key":"2109_CR23","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0086902","volume":"9","author":"K Han","year":"2014","unstructured":"Han K, Park Y-M, Kwon H-S, Ko S-H, Lee S-H, Yim HW, Lee W-C, Park YG, Kim MK, Park Y-M. Sarcopenia as a Determinant of Blood Pressure in Older Koreans: findings from the Korea National Health and Nutrition Examination Surveys (KNHANES) 2008\u20132010. PLoS ONE. 2014;9: e86902.","journal-title":"PLoS ONE"},{"key":"2109_CR24","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1038\/ejcn.2012.43","volume":"66","author":"K Sanada","year":"2012","unstructured":"Sanada K, Iemitsu M, Murakami H, Gando Y, Kawano H, Kawakami R, Tabata I, Miyachi M. Adverse effects of coexistence of sarcopenia and metabolic syndrome in Japanese women. Eur J Clin Nutr. 2012;66:1093\u20138.","journal-title":"Eur J Clin Nutr"},{"key":"2109_CR25","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.maturitas.2017.12.002","volume":"109","author":"F Bellanti","year":"2018","unstructured":"Bellanti F, Romano AD, Lo Buglio A, Castriotta V, Guglielmi G, Greco A, Serviddio G, Vendemiale G. Oxidative stress is increased in sarcopenia and associated with cardiovascular disease risk in sarcopenic obesity. Maturitas. 2018;109:6\u201312.","journal-title":"Maturitas"},{"key":"2109_CR26","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1093\/ajcn\/71.3.733","volume":"71","author":"MP Engelen","year":"2000","unstructured":"Engelen MP, Schols AM, Does JD, Wouters EF. Skeletal muscle weakness is associated with wasting of extremity fat-free mass but not with airflow obstruction in patients with chronic obstructive pulmonary disease. Am J Clin Nutr. 2000;71:733\u20138.","journal-title":"Am J Clin Nutr"},{"key":"2109_CR27","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0110448","volume":"9","author":"H-K Koo","year":"2014","unstructured":"Koo H-K, Park J-H, Park HK, Jung H, Lee S-S. Conflicting role of sarcopenia and obesity in male patients with chronic obstructive pulmonary disease: Korean National Health and Nutrition Examination Survey. PLoS ONE. 2014;9: e110448.","journal-title":"PLoS ONE"},{"key":"2109_CR28","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1183\/09031936.00197314","volume":"46","author":"C van de Bool","year":"2015","unstructured":"van de Bool C, Rutten EPA, Franssen FME, Wouters EFM, Schols AMWJ. Antagonistic implications of sarcopenia and abdominal obesity on physical performance in COPD. Eur Respir J. 2015;46:336\u201345.","journal-title":"Eur Respir J"},{"key":"2109_CR29","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1093\/bmb\/ldq008","volume":"95","author":"MV Narici","year":"2010","unstructured":"Narici MV, Maffulli N. Sarcopenia: characteristics, mechanisms and functional significance. Br Med Bull. 2010;95:139\u201359.","journal-title":"Br Med Bull"},{"key":"2109_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.imlet.2018.01.004","volume":"196","author":"S Singh","year":"2018","unstructured":"Singh S, Verma SK, Kumar S, Ahmad MK, Nischal A, Singh SK, Dixit RK. Correlation of severity of chronic obstructive pulmonary disease with potential biomarkers. Immunol Lett. 2018;196:1\u201310.","journal-title":"Immunol Lett"},{"key":"2109_CR31","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1016\/j.amjmed.2012.06.024","volume":"125","author":"S Sethi","year":"2012","unstructured":"Sethi S, Mahler DA, Marcus P, Owen CA, Yawn B, Rennard S. Inflammation in COPD: implications for management. Am J Med. 2012;125:1162\u201370.","journal-title":"Am J Med"},{"key":"2109_CR32","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1007\/s12603-009-0084-z","volume":"13","author":"WC Stephen","year":"2009","unstructured":"Stephen WC, Janssen I. Sarcopenic-obesity and cardiovascular disease risk in the elderly. JNHA J Nutr Health Aging. 2009;13:460\u20136.","journal-title":"JNHA J Nutr Health Aging"},{"key":"2109_CR33","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.118.009172","volume":"7","author":"JT Schousboe","year":"2018","unstructured":"Schousboe JT, Kats AM, Langsetmo L, Vo TN, Taylor BC, Schwartz AV, Cawthon PM, Lewis CE, Barrett-Connor E, Hoffman AR, et al. Central obesity and visceral adipose tissue are not associated with incident atherosclerotic cardiovascular disease events in older men. J Am Heart Assoc. 2018;7: e009172.","journal-title":"J Am Heart Assoc"},{"key":"2109_CR34","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.3904\/kjim.2016.193","volume":"31","author":"KM Choi","year":"2016","unstructured":"Choi KM. Sarcopenia and sarcopenic obesity. Korean J Intern Med. 2016;31:1054\u201360.","journal-title":"Korean J Intern Med"},{"key":"2109_CR35","doi-asserted-by":"publisher","first-page":"827","DOI":"10.7326\/M14-2525","volume":"163","author":"KR Sahakyan","year":"2015","unstructured":"Sahakyan KR, Somers VK, Rodriguez-Escudero JP, Hodge DO, Carter RE, Sochor O, Coutinho T, Jensen MD, Roger VL, Singh P. Normal-weight central obesity: implications for total and cardiovascular mortality. Ann Intern Med. 2015;163:827\u201335.","journal-title":"Ann Intern Med"},{"key":"2109_CR36","doi-asserted-by":"publisher","first-page":"2935","DOI":"10.1016\/j.jacc.2013.11.005","volume":"63","author":"DC Goff","year":"2014","unstructured":"Goff DC, Lloyd-Jones DM, Bennett G, Coady S, D\u2019Agostino RB, Gibbons R, Greenland P, Lackland DT, Levy D, O\u2019Donnell CJ, et al. 2013 ACC\/AHA Guideline on the assessment of\u00a0cardiovascular risk. J Am Coll Cardiol. 2014;63:2935\u201359.","journal-title":"J Am Coll Cardiol"},{"key":"2109_CR37","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.1001\/jama.2014.2630","volume":"311","author":"P Muntner","year":"2014","unstructured":"Muntner P, Colantonio LD, Cushman M, Goff DC Jr, Howard G, Howard VJ, Kissela B, Levitan EB, Lloyd-Jones DM, Safford MM. Validation of the atherosclerotic cardiovascular disease pooled cohort risk equations. JAMA. 2014;311:1406\u201315.","journal-title":"JAMA"},{"key":"2109_CR38","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1186\/1471-2261-14-163","volume":"14","author":"YC Chia","year":"2014","unstructured":"Chia YC, Lim HM, Ching SM. Validation of the pooled cohort risk score in an Asian population\u2014a retrospective cohort study. BMC Cardiovasc Disord. 2014;14:163.","journal-title":"BMC Cardiovasc Disord"},{"key":"2109_CR39","doi-asserted-by":"publisher","first-page":"25","DOI":"10.2147\/COPD.S280540","volume":"16","author":"SIJGH van Bakel","year":"2021","unstructured":"van Bakel SIJGH, Langen RC, Schols AMWJ. Towards personalized management of sarcopenia in COPD. Int J Chron Obstruct Pulmon Dis. 2021;16:25\u201340.","journal-title":"Int J Chron Obstruct Pulmon Dis"}],"container-title":["Respiratory Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12931-022-02109-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12931-022-02109-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12931-022-02109-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,13]],"date-time":"2022-07-13T22:05:21Z","timestamp":1657749921000},"score":1,"resource":{"primary":{"URL":"https:\/\/respiratory-research.biomedcentral.com\/articles\/10.1186\/s12931-022-02109-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,13]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["2109"],"URL":"https:\/\/doi.org\/10.1186\/s12931-022-02109-3","relation":{},"ISSN":["1465-993X"],"issn-type":[{"value":"1465-993X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,13]]},"assertion":[{"value":"7 September 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 July 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The Korea Centers for Disease Control and Prevention obtained written informed consent from all participants regarding the collection of their data, and the Institutional Review Board of Severance Hospital approved the study protocol (4-2021-0074). The study procedures have therefore been performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments. You may have to state that specific national laws have been observed, too.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"185"}}